Lunit
Developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology to solve the most critical issues in cancer care. Learn more
Launch date
Employees
Market cap
€907m
Enterprise valuation
€877m (Public information from Sep 2024)
Share price
KRW41900 328130.KQ
Company register number 3148650626
Seoul South Korea (HQ)
Authorizing premium user...